前列腺切除术后的辅助性与挽救性放疗
Purpose: The purpose of this guideline is to provide a clinical framework for the use of radiotherapy after prostatectomy in patients with and without evidence of prostate cancer recurrence.
Methods: A systematic review of the literature using the Pubmed, Embase, and Cochrane databases (search dates 1/1/90-12/15/12) was conducted to identify peer-reviewed publications relevant to the use of radiotherapy after prostatectomy. The review yielded an evidence base of 324 articles after application of inclusion/exclusion criteria. These publications were used to create the guideline statements. If sufficient evidence existed, then the body of evidence for a particular treatment was assigned a strength rating of A (high quality evidence; high certainty), B (moderate quality evidence; moderate certainty), or C (low quality evidence; low certainty) and evidence-based statements of Standard, Recommendation, or Option were developed. Additional information is provided as Clinical Principles and Expert Opinion when insufficient evidence existed. See text for definitions and detailed information.
上一篇: 慢性肾脏疾病的评估与管理:概要
下一篇: 癌症患者生育力的保存
文章来源:MDC
- 您可能感兴趣的指南
-